ProMedica Health System
16
1
1
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
6.3%
1 terminated/withdrawn out of 16 trials
90.9%
+4.4% vs industry average
25%
4 trials in Phase 3/4
10%
1 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis
Role: lead
Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial
Role: lead
Use of the PTEye Device to Reduce Inadvertent Parathyroidectomy During Thyroid Surgery
Role: lead
Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial
Role: lead
Clevidipine Infusion for Blood Pressure Management After Successful Revascularization in Acute Ischemic Stroke
Role: lead
Tap Block vs Conventional Pain Medication for Patients Undergoing Robotic Sacrocolpopexy
Role: lead
Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections
Role: lead
Ethyl Chloride for NPWT
Role: lead
Satisfaction Following Cesarean Section
Role: lead
ARMS-I (a Formulation of Cetylpyridinium Chloride -CPC)
Role: collaborator
Evaluating Advantages of Prevena After Hip and Knee Arthroplasty
Role: lead
Use of NAVA-catheter Positioning Screen to Identify Different Cardiac Arrhythmias
Role: lead
Comparing NAVA Levels in Intubated and Recently Extubated Neonates to Determine Optimal Non-invasive Ventilatory Support
Role: lead
Efficacy of Energy Shots and Caffeine for Energy and Wakefulness Levels
Role: lead
Effect of Daily Glucomannan in Overweight Patients
Role: lead
Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes Mellitus
Role: lead
All 16 trials loaded